| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/18/2002 | EP1266227A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 12/18/2002 | EP1266224A1 Modulation of histone deacetylase |
| 12/18/2002 | EP1266202A2 Methods for detection of differences in nucleic acids |
| 12/18/2002 | EP1266039A1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors |
| 12/18/2002 | EP1266038A2 Combined polynucleotide sequences as discrete assay endpoints |
| 12/18/2002 | EP1266037A1 High throughput screening by measurement of intracellular calcium levels |
| 12/18/2002 | EP1266036A1 Methods and compositions for identifying a protease |
| 12/18/2002 | EP1266035A1 Improved methods for generating catalytic proteins |
| 12/18/2002 | EP1266033A1 Method of reverse transcription using bacillus steraothermophilus or thermoactinomyces vulgaris dna polymerase |
| 12/18/2002 | EP1266031A1 Method for analysing the length of a nucleic acid molecule |
| 12/18/2002 | EP1266029A1 Diagnosis of a person's risk of developing alcoholism |
| 12/18/2002 | EP1266026A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta |
| 12/18/2002 | EP1266025A1 Protein scaffolds for antibody mimics and other binding proteins |
| 12/18/2002 | EP1266024A1 High fidelity reverse transcriptases and uses thereof |
| 12/18/2002 | EP1266022A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 12/18/2002 | EP1266021A2 Hypoallergenic transgenic soybeans |
| 12/18/2002 | EP1266020A2 Production of foreign polypeptides in plants as viral coat protein fusions |
| 12/18/2002 | EP1266019A1 Reduction of in planta degradation of recombinant plant products |
| 12/18/2002 | EP1266018A2 Production of secreted proteins by recombinant eukaryotic cells |
| 12/18/2002 | EP1266017A1 Vectors for the genetic transformation of lactobacillus sakei |
| 12/18/2002 | EP1266016A2 Methods for producing a polypeptide using a crippled translational initiator sequence |
| 12/18/2002 | EP1266015A2 Ecdysone receptor-based inducible gene expression system |
| 12/18/2002 | EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 12/18/2002 | EP1266013A2 Heparinase iii and uses thereof |
| 12/18/2002 | EP1266012A2 Proteases |
| 12/18/2002 | EP1266011A1 Fungal transcriptional activator useful in methods for producing polypeptides |
| 12/18/2002 | EP1266010A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 12/18/2002 | EP1266009A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 12/18/2002 | EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 12/18/2002 | EP1266007A1 Human survivin interacting protein 1 (sip-1) |
| 12/18/2002 | EP1266006A2 Production of recombinant blood clotting factors in human cell lines |
| 12/18/2002 | EP1266005A2 Regulation of human lipoxin a4 receptor-like protein |
| 12/18/2002 | EP1266004A2 Molecules of the pyrin domain protein family and uses thereof |
| 12/18/2002 | EP1266003A2 Kcnb: a potassium channel protein |
| 12/18/2002 | EP1266002A2 Il-17 receptor like molecules and uses thereof |
| 12/18/2002 | EP1266001A2 Human transcription factors |
| 12/18/2002 | EP1266000A1 Chordin-like-2 molecules and uses thereof |
| 12/18/2002 | EP1265999A2 Human schizophrenia gene |
| 12/18/2002 | EP1265998A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics |
| 12/18/2002 | EP1265997A1 43239, a gpcr-like molecule and uses thereof |
| 12/18/2002 | EP1265996A2 Identification of modulators of the interferon gamma signaling pathway and their use in restenosis treatment |
| 12/18/2002 | EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 12/18/2002 | EP1265993A1 Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activity |
| 12/18/2002 | EP1265992A2 Materials and methods relating to the degradation of cdc25a in response to dna damage |
| 12/18/2002 | EP1265991A2 Sphingomyelinase enzymes and uses relating thereto |
| 12/18/2002 | EP1265990A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 12/18/2002 | EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 12/18/2002 | EP1265988A1 Methods for transforming plant plastids and making transplastomic plants |
| 12/18/2002 | EP1265987A2 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 12/18/2002 | EP1265984A2 In ovo activation of an avian egg in the shell |
| 12/18/2002 | EP1265927A1 Crystal |
| 12/18/2002 | EP1265926A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 12/18/2002 | EP1265924A2 Il-17 receptor like molecules and uses thereof |
| 12/18/2002 | EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 12/18/2002 | EP1265919A2 G-protein associated molecules |
| 12/18/2002 | EP1265918A1 Human immune response proteins |
| 12/18/2002 | EP1265917A2 Tlp peptides and dna sequences coding the same |
| 12/18/2002 | EP1265916A2 Therapeutic anti-cytomegalovirus compounds |
| 12/18/2002 | EP1265915A2 Novel compounds |
| 12/18/2002 | EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 12/18/2002 | EP1265913A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 12/18/2002 | EP1265910A2 Nucleic acids, proteins, and antibodies |
| 12/18/2002 | EP1265712A1 Heating specimen carriers |
| 12/18/2002 | EP1265634A1 Method and composition for treating airway hyperresponsiveness |
| 12/18/2002 | EP1265630A2 Use of insulin for the treatment of cartilagenous disorders |
| 12/18/2002 | EP1265628A1 Use of human not1 and not1a orphan receptors |
| 12/18/2002 | EP1265627A2 Methods and compositions for inhibiting angiogenesis |
| 12/18/2002 | EP1265624A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 12/18/2002 | EP1265604A1 Process for recovering statin compounds from a fermentation broth |
| 12/18/2002 | EP1265484A1 Materials and methods for the regeneration of plants from cultured plant tissue |
| 12/18/2002 | EP1265480A1 Chimeric animal model susceptible to human hepatitis c virus infection |
| 12/18/2002 | EP1265477A2 Transformed plant having heterologous glucan branching enzyme activity |
| 12/18/2002 | EP1265476A2 Mqm mapping using haplotyped putative qtl-alleles: a simple approach for mapping qtl's in plant breeding populations |
| 12/18/2002 | EP1148945B1 New hydrophobic polymer comprising fluorine moieties |
| 12/18/2002 | EP1135479B1 Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis |
| 12/18/2002 | EP1036159A4 Method for purifying plasmid dna and plasmid dna substantially free of genomic dna |
| 12/18/2002 | EP1030922A4 $i(dull1) CODING FOR A STARCH SYNTHASE AND USES THEREOF |
| 12/18/2002 | EP1005479A4 Rna isolation reagent and methods |
| 12/18/2002 | EP0946721B1 Human growth gene and short stature gene region |
| 12/18/2002 | EP0904296B1 Monoclonal antibody that detects apoptotic antigen |
| 12/18/2002 | EP0892811B1 Peptides with antiproliferative properties |
| 12/18/2002 | EP0862655B1 Methods for preparing solid supports for hybridization and reducing non-specific background |
| 12/18/2002 | EP0859861A4 AMPLIFICATIONS OF CHROMOSOMAL REGION 20q13 AS A PROGNOSTIC INDICATOR IN BREAST CANCER |
| 12/18/2002 | EP0811068B1 HUMAN DNase I VARIANTS |
| 12/18/2002 | EP0805852B1 Methods for producing cytoplasmic male sterility in plants and use thereof in production of hybrid seed |
| 12/18/2002 | EP0792376B1 Continuous amplification reaction |
| 12/18/2002 | EP0789583B1 Methods and kits using macrophage stimulating protein |
| 12/18/2002 | EP0778844B1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes |
| 12/18/2002 | EP0736002B9 Compound capable of introducing at least one molecule into a cell |
| 12/18/2002 | EP0726944B1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 12/18/2002 | EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/18/2002 | EP0662150B1 Maspin, a novel serpin with tumor suppressing activity |
| 12/18/2002 | EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 12/18/2002 | EP0555370B1 Methods and applications for efficient genetic suppressor elements |
| 12/18/2002 | EP0551440B1 Design of bioactive peptides based on immunoglobulin structure |
| 12/18/2002 | EP0521996B1 Catalytic antibody components |
| 12/18/2002 | CN1386135A Phytomics: a genomic-based approach to herbal compositions |
| 12/18/2002 | CN1386134A Process for producing gamma-glutamylcysteine |
| 12/18/2002 | CN1385539A Garrupa growth hormone gene, carrier having same, strains and production and use for expressino products |
| 12/18/2002 | CN1385538A Broad-spectrum plasmid stabilizing factor PSF-Cxc and separation method and use thereof |